| Literature DB >> 31395803 |
Andres Bernal-Ballen1, Jorge-Andres Lopez-Garcia2, Kadir Ozaltin2.
Abstract
Chitosan, fucoidan, and polyvinyl alcohol are categorized as polymers with biomedical applications. Ampicillin, on the other hand, is considered as an important antibiotic that has shown effectivity in both gram-positive and gram-negative micro-organisms. The aforementioned polymers possess unique properties that are considered desirable for cell regeneration although they exhibit drawbacks that can affect their final application. Therefore, films of these biomaterials were prepared and they were characterized using FTIR, SEM, XRD, degree of swelling and solubility, and MTT assay. The statistical significance of the experiments was determined using a two-way analysis of variance (ANOVA) with p < 0.05. The characterization techniques demonstrated that the obtained material exhibits properties suitable for cell regeneration, and that a higher concentration of natural polymers promotes cells proliferation to a greater extent. The presence of PVA, on the other hand, is responsible for matrix stability and dictates the degree of swelling and solubility. The SEM images demonstrated that neither aggregations nor clusters were formed, which is favorable for the biological properties without detrimental to the morphological and physical features. Cell viability was comparatively similar in samples with and without antibiotic, and the physical and biological properties were not negatively affected. Indeed, the inherent bactericidal effect of chitosan was reinforced by the presence of ampicillin. The new material is an outstanding candidate for cell regeneration as a consequence of the synergic effect that each component provides to the blend.Entities:
Keywords: ampicillin; bioartificial polymeric material; cell proliferation; chitosan; fucoidan; polyvinyl alcohol
Year: 2019 PMID: 31395803 PMCID: PMC6724007 DOI: 10.3390/polym11081325
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
List of the prepared BAPMs and the ratio of all the components.
| Description |
|---|
| PVA |
| CHI |
| PVA/CHI/AMP 1:1 |
| PVA/CHI/AMP 2:1 |
| PVA/CHI/AMP 1:2 |
| PVA/CHI 1:1 |
| PVA/CHI 2:1 |
| PVA/CHI 1:2 |
| PVA/CHI/FUCOIDAN/AMP 1:1 |
| PVA/CHI/FUCOIDAN/AMP 2:1 |
| PVA/CHI/FUCOIDAN/AMP 1:2 |
| PVA/CHI/FUCOIDAN 1:1 |
| PVA/CHI/FUCOIDAN 2:1 |
| PVA/CHI/FUCOIDAN 1:2 |
Note: The ratio indicates the relationship between synthetic (PVA) and natural (both CHI/FUC) polymers.
Figure 1FTIR for the obtained BAPM. (a) Row materials; (b) PVA/CHI/AMP samples; (c) PVA/CHI samples; (d) PVA/CHI/FUC/AMP samples; and (e) PVA/CHI/FUC samples.
List of the XPS spectra given in atomic percent of all the components.
| Samples | C1s% | O1s% | N1s% | S2p% |
|---|---|---|---|---|
| PVA/CHI/AMP 1:1 | 69.3 | 26.0 | 4.6 | 0.1 |
| PVA/CHI/AMP 2:1 | 77.1 | 21.3 | 1.6 | 0.1 |
| PVA/CHI/AMP 1:2 | 70.3 | 24.7 | 4.8 | 0.2 |
| PVA/CHI 1:1 | 67.1 | 28.1 | 4.7 | - |
| PVA/CHI 2:1 | 70.0 | 26.2 | 3.7 | - |
| PVA/CHI 1:2 | 67.6 | 27.5 | 4.9 | - |
| PVA/CHI/FUC/AMP 1:1 | 69.2 | 26.3 | 4.4 | 0.2 |
| PVA/CHI/FUC/AMP 2:1 | 72.5 | 25.6 | 2.0 | - |
| PVA/CHI/FUC/AMP 1:2 | 69.8 | 25.9 | 4.4 | - |
| PVA/CHI/FUC 1:1 | 70.2 | 26.2 | 3.6 | 0.1 |
| PVA/CHI/FUC 2:1 | 68.6 | 27.0 | 4.1 | 0.2 |
| PVA/CHI/FUC 1:2 | 75.7 | 20.8 | 3.3 | 0.1 |
Figure 2XPS spectra for (a) PVA/CHI/AMP 1:2; (b) PVA/CHI/ 1:2; (c) PVA/CHI/FUC/AMP 1:2; (d) PVA/CHI/FUC 1:2.
Figure 3SEM images for BAPM in the presence of AMP. (a) PVA/CHI/AMP 1:1; (b) PVA/CHI/AMP 2:1; (c) PVA/CHI/AMP 1:2; (d) PVA/CHI/FUC/AMP 1:1; (e) PVA/CHI/FUC/AMP 2:1; and (f) PVA/CHI/FUC/AMP 1:2.
Degree of swelling and solubility degree for the prepared BAPM.
| MATERIAL | Degree of Swelling after 6 h [%] (SD) | Average Weight Loss [%] (SD) |
|---|---|---|
| PVA | 1652 ± 337 | 36 ± 10 |
| CHI | 354 ± 45 | 32 ± 3 |
| PVA/CHI/AMP 1:1 | 1364 ± 258 | 49 ± 7 |
| PVA/CHI/AMP 2:1 | 1448 ± 148 | 52 ± 8 |
| PVA/CHI/AMP 1:2 | 1301 ± 225 | 35 ± 10 |
| PVA/CHI 1:1 | 1160 ± 244 | 52 ± 5 |
| PVA/CHI 2:1 | 1263 ± 344 | 61 ± 3 |
| PVA/CHI 1:2 | 1032 ± 108 | 36 ± 8 |
| PVA/CHI/FUCOIDAN/AMP 1:1 | 1324 ± 208 | 36 ± 5 |
| PVA/CHI/FUCOIDAN/AMP 2:1 | 1342 ± 76 | 54 ± 13 |
| PVA/CHI/FUCOIDAN/AMP 1:2 | 1169 ± 303 | 31 ± 10 |
| PVA/CHI/FUCOIDAN 1:1 | 1159 ± 173 | 36 ± 3 |
| PVA/CHI/FUCOIDAN 2:1 | 1414 ± 404 | 38 ± 12 |
| PVA/CHI/FUCOIDAN 1:2 | 1227 ± 44 | 38 ± 6 |
Figure 4Cell viability of the BAPM (MTT assay).